New hope for toddlers with swallowing disorder? drug trial launches

NCT ID NCT07112378

First seen Oct 31, 2025 · Last updated May 10, 2026 · Updated 19 times

Summary

This study tests an experimental drug, dupilumab, in 20 young children (6 months and older, weighing 5 to 15 kg) with active eosinophilic esophagitis (EoE), a condition that causes throat inflammation and feeding problems. The goal is to see if the drug is safe and can reduce inflammation over 24 weeks. Researchers will also monitor side effects and how the drug behaves in the body.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EOSINOPHILIC ESOPHAGITIS (EOE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Children's Hospital Colorado

    RECRUITING

    Aurora, Colorado, 80045, United States

  • Cook Children's Medical Center

    RECRUITING

    Fort Worth, Texas, 76104, United States

  • GI Care for Kids LLC

    RECRUITING

    Atlanta, Georgia, 30342, United States

  • Medical University of South Carolina

    RECRUITING

    Charleston, South Carolina, 29425, United States

  • Phoenix Childrens Hospital

    RECRUITING

    Phoenix, Arizona, 85016, United States

  • University of North Carolina, Bioinformatics Building

    RECRUITING

    Chapel Hill, North Carolina, 27599, United States

  • University of Virginia

    RECRUITING

    Charlottesville, Virginia, 22908, United States

  • Weill Cornell Medicine

    RECRUITING

    New York, New York, 10065, United States

Conditions

Explore the condition pages connected to this study.